The Isthmus Logic Post Market Clinical Follow-up Study

Isthmus Logic Carbostent™ is a CE-marked cobalt chromium stent with a bio inducer surface for the treatment of peripheral iliac artery disease.The aim of this post-market retrospective study protocl P22202 is to collect clinical data of patients treated with Isthmus Logic for the treatment of peripheral iliac artery disease in routine clinical practice.In order to obtain long-term follow-up data, the data collection will be limited to patients that have been treated with these devices at least 12 months prior to the study start.

Inclusion Criteria:Patient has been implanted with at least one Isthmus Logic stent according to the indications described in the Instructions for Use (IFU).Study device implantation date is at least one year (12 months) prior to the starting date of the retrospective anonymous data collection.Exclusion Criteria:Patients treated less than 12 months prior to study start